Oragenics Files 8-K Report
Ticker: OGEN · Form: 8-K · Filed: Mar 18, 2024 · CIK: 1174940
| Field | Detail |
|---|---|
| Company | Oragenics INC (OGEN) |
| Form Type | 8-K |
| Filed Date | Mar 18, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $400 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
Oragenics filed a routine 8-K, no major news.
AI Summary
On March 18, 2024, Oragenics, Inc. filed an 8-K report detailing "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific financial figures or new material events beyond the standard reporting requirements.
Why It Matters
This filing indicates Oragenics, Inc. is meeting its regulatory reporting obligations with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a standard regulatory report and does not disclose any new material risks or events.
Key Players & Entities
- Oragenics, Inc. (company) — Registrant
- March 18, 2024 (date) — Date of Report
FAQ
What is the purpose of this 8-K filing for Oragenics, Inc.?
The purpose of this 8-K filing is to report "Other Events" and "Financial Statements and Exhibits" as of March 18, 2024.
What is Oragenics, Inc.'s state of incorporation?
Oragenics, Inc. is incorporated in Florida (FL).
What is the principal executive office address for Oragenics, Inc.?
The principal executive offices are located at 1990 Main Street, Suite 750, Sarasota, FL 34236.
What is the telephone number for Oragenics, Inc.?
The telephone number for Oragenics, Inc. is 813-286-7900.
What is the SIC code for Oragenics, Inc.?
The Standard Industrial Classification (SIC) code for Oragenics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 448 words · 2 min read · ~1 pages · Grade level 10.4 · Accepted 2024-03-18 07:38:33
Key Financial Figures
- $400 — of service per month to the Company (at $400 per hour). A copy of the Press Release
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex99-1.htm (EX-99.1) — 16KB
- 0001493152-24-010192.txt ( ) — 231KB
- ogen-20240318.xsd (EX-101.SCH) — 3KB
- ogen-20240318_lab.xml (EX-101.LAB) — 33KB
- ogen-20240318_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 18 th day of March, 2024. ORAGENICS, INC. (Registrant) BY: /s/ Janet Huffman Janet Huffman Chief Financial Officer